AkiraBio
1 known investors
Find your way into AkiraBio
Sign up to see every warm intro you have to AkiraBio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AkiraBio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Akira Bio develops therapies for people living with sickle cell disease and other hemoglobinopathies. It is a biotechnology company focused on treatments for blood disorders.
Investors · 1
Frequently asked questions
- What does AkiraBio do?
- Akira Bio develops therapies for people living with sickle cell disease and other hemoglobinopathies. It is a biotechnology company focused on treatments for blood disorders.
- Who are AkiraBio's investors?
- AkiraBio's investors include Vivo Capital.

